Specifically, we examine how abnormalities in the p53/AMPK/mTOR signaling pathways contribute to lesion formation and progression, as well as to reduced fertility potential, with the ultimate goal of advancing our understanding of endometriosis pathophysiology and informing the development of novel therapeutic strategies. Here, MTOR is linked to endometriosis.